Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure

NCT ID: NCT00800228

Last Updated: 2008-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-03-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the hypothesis that blood pressure sensitivity to high sodium intake in healthy humans is characterized by increased urinary excretion of two endogenous sodium pump inhibitors, marinobufagenin (MBG), and ouabain-like compound (OLC). The study also tests the hypothesis that women who breathe slowly and have high resting end tidal CO2 at rest are more likely to have low plasma renin activity and sodium sensitivity of blood pressure than those who breathe more rapidly and maintain lower end tidal CO2.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The experiments will involve a common procedure of sodium restriction followed by sodium loading of normotensive (having normal blood pressure) humans. However, the first experiment will involve continuous urine collection throughout the experimental period in a smaller group of men and women, while the second experiment will involve urine collection only at the end of each diet period in a larger group of normotensive women. If, as expected, experiment one shows that sodium loading produces MBG increases that are sustained throughout the sodium loading period, then experiment two will also be able to address a third issue: that is whether MBG or OLC response to sodium loading is specific to breathing pattern or sodium sensitivity. It is hypothesized that women with inhibited breathing who are sodium sensitive will show higher levels of MBG, even before sodium loading, but also following sodium loading.

Each participant will be seen at the Clinical Research Unit for a screening visit and on days 6 and 12, and consume a low sodium diet for 6 days followed by a high sodium diet for 6 days. Research staff will meet with the participant at regular intervals for meal provision and transfer of 24-hr urine collections (if applicable). Respiration and blood pressure will be measured on the last day of each sodium diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

salt blood pressure breathing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Eight men and eight women to define the time course of changes in MBG \\ and OLC accompanying sodium loading

No interventions assigned to this group

2

32 additional women to determine whether breathing pattern is predictive of sodium sensitivity in that gender. Women are being studied in the second experiment because they, but not men, have been shown to have an association of breathing pattern with high perceived stress11 and an association of high resting end tidal CO2 with high resting blood pressure.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 40-70
* Caucasian
* Nonsmoking
* Free of respiratory, cardiac, liver and kidney disease, and diabetes
* Resting systolic blood pressure less than or equal to 139 mmHg AND resting diastolic blood pressure of less than or equal to 89 mmHg15
* BMI less than or equal to 30
* Negative pregnancy test for female participants whose last menstrual period was less than one year prior to study enrollment
* For Group 1, willing to provide 24-hr urine samples for 12 consecutive days
* For Group 2, women on combination oral contraceptives (those containing estrogen and progesterone) will be eligible for the study, with equal numbers in the "fast" and "slow" breathing groups
* For Group 2, in premenopausal women, regular menstrual cycles for at least 6 months prior to study entry

Exclusion Criteria

* Presence of respiratory, cardiac, liver or kidney disease; diabetes, or hypertension
* Use of medications which can affect respiratory rate, such as major tranquilizers, narcotics, or benzodiazepines
* Diuretic or steroid use
* Cigarette smoking within the past 12 months
* BMI \> 30 kg/m2
* Postmenopausal women on hormone replacement therapy
* Pregnancy or lactation in the last 12 months
* In premenopausal women, irregular menstrual cycles in the 6 months prior to study entry
* For Group 2, respiratory rate in the middle third of the distribution of breathing frequency in BLSA
* For Group 2, pre-menopausal women not taking oral contraceptives who are in the follicular phase of the menstrual cycle
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

National Institute on Aging, NIH

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Anderson, PhD

Role: PRINCIPAL_INVESTIGATOR

National Institute on Aging (NIA)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NIA Clinical Research Unit

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Muntzel M, Drueke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens. 1992 Apr;5(4 Pt 1):1S-42S. doi: 10.1093/ajh/5.4s.1s.

Reference Type BACKGROUND
PMID: 1599633 (View on PubMed)

Haddy FJ. Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium. Cardiovasc Drugs Ther. 1990 Mar;4 Suppl 2:343-9. doi: 10.1007/BF02603174.

Reference Type BACKGROUND
PMID: 2176807 (View on PubMed)

Doris PA, Bagrov AY. Endogenous sodium pump inhibitors and blood pressure regulation: an update on recent progress. Proc Soc Exp Biol Med. 1998 Jul;218(3):156-67. doi: 10.3181/00379727-218-44283.

Reference Type BACKGROUND
PMID: 9648933 (View on PubMed)

Fedorova OV, Anderson DE, Lakatta EG, Bagrov AY. Interaction of NaCl and behavioral stress on endogenous sodium pump ligands in rats. Am J Physiol Regul Integr Comp Physiol. 2001 Jul;281(1):R352-8. doi: 10.1152/ajpregu.2001.281.1.R352.

Reference Type BACKGROUND
PMID: 11404312 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AG0110

Identifier Type: -

Identifier Source: org_study_id